Overview
CHICAGO — McDermott Will & Emery and Ernst & Young will host a series of dynamic and interactive programs in conjunction with the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, enabling progressive leaders to leverage Collaborative Transformations – game-changing partnerships and acquisition opportunities that drive bold and creative business solutions – to grow and thrive in the changing health landscape.
Held at the Ritz-Carlton San Francisco January 7 – 9th, presenters and attendees will come together to discuss how new approaches to collaboration and dealmaking, changing cross-border dynamics, and emerging technology are pushing the health industry forward, and to share best practices for avoiding being left behind as health care and life sciences industries continue evolving.
The programming will include multiple forums and panel discussions, covering a variety of hot industry topics, including:
• Strategies to counter increased competition from traditional and non-traditional health industry players
• Leading transactions that collaborate across traditional industry divides
• Cross-border partnerships between life sciences companies/investors in China, Europe and the US
• Ways new and innovative technology products are re-shaping traditional health care
• How private equity investment is facilitating growth of behavioral health providers and physician practice management
An array of health care and life sciences industry players will share their perspectives over the course of these events, including executives from CVS Health, Blackstone, Boston Children’s Hospital, Massive Bio, Steward Health Care, Voluntis and Welsh Carson Anderson & Stowe. Featured programming will include:
Monday, January 7th:
• Hospital/Health System Collaborative Transformation Forum, 10: 30 a.m. – 1:05 p.m.
Including multiple panel discussions, featuring Mudit Garg, Chief Executive Officer & Founder, Qventus, Carla Small, Senior Director of the Innovation and Digital Health Accelerator, Boston Children’s Hospital, Brett M. Hickman, Executive Vice President, Optum, Sara Rau, Deputy General Counsel, Steward Health Care System LLC, Mark Rich, Healthcare Executive: Finance, Strategy & Business Development Expertise, Steward Health Care System LLC, Nicholas Archer, Chief Executive Officer, Project Fulcrum, Florida Hospital, Richard Mulry, Chief Operating Officer, True North, Patrick Pilch, CPA, MBA, Managing Director and National Leader, BDO, and Scott Powder, Chief Strategy Officer, Advocate Aurora Health.
• China: New El Dorado or Great Wall for Life Sciences Companies?, 4:00 – 7:00 p.m.
Featuring Jerry (Wansheng) Liu, President Elect, Sino-American Pharmaceutical Professionals Association, Antoine Papiernik, Chairman, Sofinnova Partners, Steven Shill, Partner and National Leader of Healthcare Industry Group, BDO, Jonathan Wang, Co-Founder & Partner, OrbiMed Asia, and Lianshan Zhang, President of Global R&D, Jiangsu Hengrui Medicine.
Tuesday, January 8th:
• Smart Health Care Leaders Forum, 8:30 a.m. – 2:30 p.m.
Featuring Dr. Robert Galvin, Operating Partner of Equity Healthcare, Blackstone, Thomas Moriarty, General Counsel and Director of External Affairs, CVS Health, Peter Orszag former Director of the Office of Management and Budget and Global Co-Head of Healthcare, Lazard, and Thomas Scully, former Administrator of the Centers for Medicare and Medicaid Services and General Partner, Welsh Carson Anderson & Stowe.
• SPIN Annual Cocktail Reception, 7:00 – 11:00 p.m., SPIN San Francisco.
Network and connect with more than 600 industry peers at the premiere cocktail event of the entire week. Enjoy an evening of handcrafted cocktails, farm-to-table bites and a game or two of ping pong.
Wednesday, January 9th:
• A Lunchtime Conversation with Digital Health Pioneers, 11:00 a.m. – 1:30 p.m.
Featuring Peggy Baxter, Chief of Staff & Vice President of Network Engagement, AVIA, Selin Kurnaz, PhD, Co-founder and CEO, Massive Bio, Inc., Pierre Leurent, Chief Executive Officer, Voluntis, and Elia Stupka, Chief Analytics Officer and SVP – Life Sciences Business, Health Catalyst Inc.
To register for McDermott and Ernst & Young’s J.P. Morgan Healthcare Conference programming, review event agendas or to schedule a consultation with a Firm attorney onsite, please visit the online registration portal. For more information about our approach to Collaborative Transformation, visit MWE.com/CollaborativeTransformation.
McDermott Will & Emery is the nation’s leading health care law firm. The Health Industry Advisory group is the only health practice to receive top national rankings from U.S. News – Best Lawyers “Best Law Firms,” Chambers USA, The Legal 500 US, and Law360. The practice was also recognized by Chambers as “Health Team of the Year” in 2010, 2013 and 2017. Since 2017, McDermott has taken the top spot in PitchBook’s League Tables as the most active firm for health care private equity.
McDermott’s global Life Sciences Team fuels the mission of life sciences companies, leveraging a purpose-built and dedicated group of lawyers with demonstrated strengths across intellectual property, regulatory, transactional, employment and litigation law. Combining industry leadership and passion for the work they do – and leveraging the Firm’s deep health care experience – team members are routinely listed as “Life Sciences Stars” by LMG Life Sciences. Additionally, the Life Sciences Intellectual Property team was ranked as a leading US practice in Life Sciences on Managing IP’s “2018 IP Stars” list.
About McDermott Will & Emery
McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,000 lawyers, we have offices in Boston, Brussels, Chicago, Dallas, Düsseldorf, Frankfurt, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, San Francisco, Seoul, Silicon Valley and Washington, DC. Further extending our reach into Asia, we have a strategic alliance with MWE China Law Offices in Shanghai.